IMO you are absolutely not late to investing in CYDY. I am buying more next week and raising my cost average. We are discussing cancer here, but there are many possibilities with leronlimab. It is a stellar HIV drug and undervalued significantly on HIV alone (if sales can execute). They are testing it for NASH. Many HIV patients have NAFLD/NASH comorbidity. Etc. My opinion.
Market Data 
Markets 
AI
